Health Condition 1: K011- Impacted teeth
Conditions
Interventions
Intervention1: dexmedetomidine: 1.5mcg/kg Dose
intranasal spray Route -Nasal
Control Intervention1: Normal saline: 1.5mcg/kg Dose
intranasal spray Route - Nasal
Sponsors
DrMrudulaRavindra Mulay Self
Eligibility
Inclusion criteria
Inclusion criteria: 1. The participants with carious tooth / impacted tooth which needs to be removed by transalveolar method. 2. Participants above age group of 18 and below the age of 60. 3. Participants of both the genders will be included. 4. Participant who are physically and medically fit for the surgery. 5. Patients undergoing transalveolar extractions and willing to participate in the study (with informed consent)
Exclusion criteria
Exclusion criteria: 1. Medically compromised patients with extremes of ages. 2. Patients not willing for the study 3. Patients with allergic rhinitis, breathing disorders and running nose. 4. Patients allergic to dexmedetomidine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will enable us to whether intranasal dexmedetomidine spray will provide better anxiety control and sedation or not in patients undergoing transalveolar extractions under local anesthesia with adrenaline. Timepoint: Baseline (15min before surgery) 0 Minutes (Immediately After spray) 15 Minutes (Immediately After Injecting LA) 30 Minutes 45 Minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| evaluate and compare the anxiety level, sedation status of the patient following intranasal dexmedetomidine spray and intranasal saline spray as a placebo effect during transalveolar extractions.Timepoint: Baseline (15min before surgery) 0 Minutes (Immediately After spray) 15 Minutes (Immediately After Injecting LA) 30 Minutes 45 Minutes | — |
Countries
India
Contacts
Public ContactDr Mrudula Ravindra Mulay
Sumandeep Vidyapeeth
Outcome results
None listed